chr17-1496145-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016532.4(INPP5K):āc.1205A>Gā(p.Asn402Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,612,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016532.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INPP5K | NM_016532.4 | c.1205A>G | p.Asn402Ser | missense_variant | 11/12 | ENST00000421807.7 | NP_057616.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INPP5K | ENST00000421807.7 | c.1205A>G | p.Asn402Ser | missense_variant | 11/12 | 1 | NM_016532.4 | ENSP00000413937.2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250956Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135666
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1459886Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726372
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74354
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2021 | The c.1205A>G (p.N402S) alteration is located in exon 11 (coding exon 11) of the INPP5K gene. This alteration results from a A to G substitution at nucleotide position 1205, causing the asparagine (N) at amino acid position 402 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at